STOCK TITAN

IMAX CORP (IMAX) CMO logs RSU conversions, new grant and tax withholding

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

IMAX CORP Chief Marketing Officer Anne Globe reported several equity compensation transactions dated March 7, 2026. She converted 12,225 and 5,500 vested restricted share units into the same number of common shares, reflecting routine settlement of prior awards. She also received a new grant of 12,512 restricted share units, each economically equivalent to one common share. To cover tax obligations related to the share delivery, IMAX Corporation withheld 6,904 common shares at $40.80 per share rather than selling them in the market. Following these transactions, Globe holds 18,574 common shares and 35,739 restricted share units in total.

Positive

  • None.

Negative

  • None.
Insider Globe Anne
Role Chief Marketing Officer
Type Security Shares Price Value
Exercise restricted share units 12,225 $0.00 --
Exercise restricted share units 5,500 $0.00 --
Grant/Award restricted share units 12,512 $0.00 --
Exercise common shares 12,225 $0.00 --
Exercise common shares 5,500 $0.00 --
Tax Withholding common shares 6,904 $40.80 $282K
holding common shares (opening balance) -- -- --
Holdings After Transaction: restricted share units — 12,227 shares (Direct); common shares — 19,978 shares (Direct); common shares (opening balance) — 7,753 shares (Direct)
Footnotes (1)
  1. Represents the conversion of vested restricted share units into common shares. Ms. Globe is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon the conversion of the restricted shares unit transaction. Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. The restricted share units vest and will be converted to common shares in three installments: 12,225 on each of March 7, 2025 and March 7, 2026 and 12,227 on March 7, 2027. The restricted share units vest and will be converted to common shares in three equal installments: 5,500 on each of March 7, 2026, March 7, 2027 and March 7, 2028. The restricted share units vest and will be converted to common shares in three installments: 4,170 on each of March 7, 2027 and March 7, 2028 and 4,172 on March 7, 2029. This represents the number of restricted share units for this transaction only. Ms. Globe's aggregate remaining restricted share units and common share balances following these transactions are 35,739 and 18,574, respectively.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Globe Anne

(Last) (First) (Middle)
IMAX CORPORATION
12582 WEST MILLENNIUM DRIVE

(Street)
LOS ANGELES CA 90094

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
IMAX CORP [ IMAX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Marketing Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/07/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
common shares (opening balance) 7,753 D
common shares 03/07/2026 M 12,225(1) A $0.00 19,978 D
common shares 03/07/2026 M 5,500(2) A $0.00 25,478 D
common shares 03/07/2026 F 6,904 D $40.8 18,574 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
restricted share units(3) $0.00(4) 03/07/2026 M 12,225 (5) (5) common shares 12,225 $0.00(4) 12,227(8) D
restricted share units(3) $0.00(4) 03/07/2026 M 5,500 (6) (6) common shares 5,500 $0.00(4) 11,000(8) D
restricted share units(3) $0.00(4) 03/07/2026 A 12,512 (7) (7) common shares 12,512 $0.00(4) 12,512(8) D
Explanation of Responses:
1. Represents the conversion of vested restricted share units into common shares.
2. Ms. Globe is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon the conversion of the restricted shares unit transaction.
3. Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation.
4. Each restricted share unit is the economic equivalent of one common share of IMAX Corporation.
5. The restricted share units vest and will be converted to common shares in three installments: 12,225 on each of March 7, 2025 and March 7, 2026 and 12,227 on March 7, 2027.
6. The restricted share units vest and will be converted to common shares in three equal installments: 5,500 on each of March 7, 2026, March 7, 2027 and March 7, 2028.
7. The restricted share units vest and will be converted to common shares in three installments: 4,170 on each of March 7, 2027 and March 7, 2028 and 4,172 on March 7, 2029.
8. This represents the number of restricted share units for this transaction only. Ms. Globe's aggregate remaining restricted share units and common share balances following these transactions are 35,739 and 18,574, respectively.
Remarks:
/s/ Kenneth I. Weissman (attorney-in-fact for Anne Globe) 03/10/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did IMAX (IMAX) Chief Marketing Officer Anne Globe report?

Anne Globe reported converting vested restricted share units into common shares, receiving a new restricted share unit grant, and having shares withheld to cover taxes. These actions reflect routine equity compensation activity rather than open-market buying or selling of IMAX common shares.

How many IMAX common shares did Anne Globe acquire through restricted share unit conversions?

Anne Globe converted 12,225 and 5,500 vested restricted share units into the same number of IMAX common shares. These conversions settled previously granted awards, increasing her direct common share holdings without an open-market purchase at a stated cash exercise price.

What new equity award did Anne Globe receive from IMAX on March 7, 2026?

She received a grant of 12,512 restricted share units on March 7, 2026. Each restricted share unit represents the right to receive one IMAX common share and is economically equivalent to a common share, subject to the vesting schedule described in the footnotes.

Were any of Anne Globe’s IMAX share transactions open-market sales?

No open-market sales were reported. Instead, 6,904 common shares were withheld by IMAX Corporation at $40.80 per share solely to satisfy tax withholding obligations arising from restricted share unit conversions, a standard non-market mechanism for paying related tax liabilities.

How many IMAX shares and restricted share units does Anne Globe hold after these transactions?

After the reported transactions, Anne Globe holds 18,574 IMAX common shares and 35,739 restricted share units. These figures, disclosed in the footnotes, show her continuing equity stake through both outright share ownership and unvested or unsettled restricted share unit awards.

What vesting schedules apply to Anne Globe’s IMAX restricted share units?

Her restricted share units vest in three-installment schedules on specified March 7 dates from 2025 through 2029, with tranche sizes such as 12,225, 5,500 and 4,170 units. Upon vesting, each restricted share unit converts into one IMAX common share as outlined in the footnotes.